Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
Toni Luise Meister(Universität Hamburg), Stephanie Pfaender(Leibniz Institute of Virology (LIV)), Maike Herrmann(Carl von Ossietzky Universität Oldenburg), Ingo Drexler(Düsseldorf University Hospital), Maximilian K. Nocke(Ruhr University Bochum), Bettina Wiegmann(Medizinische Hochschule Hannover), Nina Babel(Universitätsklinik Marien Hospital Herne), Daniel Tödt(Ruhr University Bochum), Susanne Pfefferle(Universität Hamburg), Krzysztof P. Lubieniecki(Simon Fraser University), Richard J. P. Brown(Paul Ehrlich Institut), Huu Phuc Nguyen(University Hospitals of the Ruhr-University of Bochum), Thomas Burkard(Ruhr University Bochum), Natalie Heinen(Ruhr University Bochum), Eike Steinmann(University Hospitals of the Ruhr-University of Bochum), Kristina Döring(Heidelberg University), Ronny Tao(Heinrich Heine University Düsseldorf), Sibylle Haid(Center for Experimental and Clinical Infection Research), Nadine Ebert(University of Bern), Joanna M. Lubieniecka(Child and Family Research Institute), Bettina Salome Trüeb(University of Bern), Volker Thiel(University of Bern), Thomas Pietschmann(German Center for Infection Research), Saskia Westhoven(Institute of Virology of the Slovak Academy of Sciences), Yannick Brüggemann(Hepatitis B Foundation), Marylyn M. Addo(Universität Hamburg), Lisa Thomann(University of Bern)
Cited by 2
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
|Nature|2013|2.1k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k